West Physics is the premier national provider of diagnostic medical and health physics consulting and testing services in the United States. Because of our absolute commitment to both technical and service quality, WPC has grown from serving a single local client in 2002 to serving well over 1,000 clients in 49 U.S. States, federal territories, the Caribbean and Latin America currently - and we continue to grow. Our customers are among the most respected hospitals, imaging centers and healthcare networks in the country and we delight in continually exceeding their expectations. Our staff specializes in complex problems and modalities and their diverse backgrounds and top-notch training result in superior diagnostic capabilities and an unequaled breadth of expertise. Because of our business model, we are able to provide local-style response times and pricing combined with national expertise and consistency.
Are you paying too much in Property Taxes?
Property Valuation Services employs Healthcare Professionals who have operated, serviced, sold and managed healthcare related facilities and equipment. This knowledge, combined with the expertise of our Tax Professionals (including former Healthcare Property Tax Portfolio Managers) and the testament of our current Client base, clearly gives PVS the right to stake its claim as the “Property Tax Specialists in Healthcare”. Let us show you how we can reduce your taxable liability this year and every year to follow.
For more information, visit www.propertyvaluationservices.net.
MBMS has been servicing radiology practices for more than a quarter century and currently provides billing for more than 450 radiologists. As one of the largest and best-performing billing companies in the country, MBMS is able to provide its clients with exceptional customer service and unparalleled financial results.
As a technology leader, MBMS provides its clients with industry leading enhancements such as the MBMS Digital Lockbox and the MBMS Automated Billing Process, which reduces errors and improves turnaround time, allowing us to provide a higher clean claims rate, lower days on books, and better net collections than other firms. MBMS also delivers unlimited access to the most powerful reporting and business analytics tool in radiology, Discover. This technology affords clients with complete transparency into the billing process and allows users to create customized dashboard reports on the fly.
For more information, please visit www.mbms.net or contact Matt Ostrum at (610) 564-5314.
Medical Mutual Insurance Company of North Carolina(MMIC) is one of the nation's largest and most successful providers of medical professional liability insurance. In operation for 42 years, MMIC protects nearly 13,000 physicians authorized to do business in 32 states—including more than 1,300 radiologists—and has enjoyed an "A" (Excellent) financial strength rating by A.M. Best for 14 consecutive years. MMIC is an affiliate of Medical Mutual Holdings, Inc., a platform company that provides a broad range of services for physicians and medical practices, including SharpVue Capital, a wealth and asset management firm for physicians, other medical professionals, and institutional investors.
For more information, please visit www.medicalmutualgroup.com or contact Nicholas Belutty at office 484-220-1636 or cell 609-335-1247.
Veracyte, Inc., based in South San Francisco, Calif., offers the Afirma® Thyroid FNA Analysis, a comprehensive thyroid nodule management solution which combines specialist cytopathology assessment with the Afirma Gene Expression Classifier (GEC). The GEC classifies inconclusive thyroid nodule cytology results as benign or suspicious for cancer. The results of a large, prospective, multi-center validation study, recently published in the New England Journal of Medicine, confirmed that the Afirma Gene Expression Classifier identifies benign nodules with high accuracy. Additional studies have shown that physicians incorporating the Afirma Thyroid FNA Analysis into their practice have routinely chosen to follow patients with cytology indeterminate and Gene Expression Classifier Benign results in lieu of surgery, therefore improving care and reducing costs for patients and the healthcare system. Veracyte has formed a global co-promotion partnership with Genzyme, a Sanofi company, to make the Afirma Thyroid FNA Analysis available throughout the U.S. and, subsequently, globally.